DeVita: It Was Time To Go, and The Action Is Not A Memorial: Says He’ll Work Well With Paul Marks
In Brief: Senate Tracks Reauthorization n New Institute Bill, Waxman May Go Along: Abe Goldin Dies
DeVita Era At NCI One Of New Programs, Remarkable Stability
NCI Facing Extended Tie Under Acting Director – Maybe
ONS Opposes AMA On “Registered Care Technologist”
NIGMS Awards First Grants For Gene Mapping
Trending Stories
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - George Sigounas named the first-ever chief science advisor at NCI
- In The Headlines: Increasing incidence of early-onset cancer is “a paradigm shift oncology isn’t quite prepared for”
- Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State
- Loss of Y chromosome “cripples” immune cells, University of Arizona researcher finds
Cells with LOY may induce LOY in otherwise healthy cells—a finding that could explain variability in CAR T-cell therapy response